UniProt/SwissProt ID: | TOP1_HUMAN |
Description: | topoisomerase (DNA) I [Source:HGNC Symbol;Acc:11986] |
Location: | chr20 q12 |
Node attribute: | substrate; gene |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S423 | ENIQGsIKYIM | Topoisom_I_N | PhosphoSitePlus |
S57 | SEHKDsEKKHK | PhosphoSitePlus; HPRD | |
Y268 | MLDHEyTTKEI | Topoisom_I_N | PhosphoSitePlus |
S2 | DHLH | HPRD; SysPTM | |
S21 | FRLNDsHKHKD | PhosphoSitePlus; HPRD | |
Y723 | TSKLNyLDPRI | Hanta_nucleocap; Topo_C_a | PhosphoSitePlus |
S111 | KENGFsSPPQI | PhosphoSitePlus; HPRD | |
T303 | SKCDFtQMSQY | Topoisom_I_N | PhosphoSitePlus |
Y268 | MLDHEyTTKEI | Abl | phosphoELM |
S432 | IMLNPsSRIKG | HPRD | |
S2 | ____MsGDHLH | PhosphoSitePlus; SysPTM | |
S73 | KHKDGsSEKHK | PhosphoSitePlus; HPRD | |
S394 | DAKVPsPPPGH | Topoisom_I_N | PhosphoSitePlus |
Y268 | MLDHEyTTKEI | ABL1 | RegPhos |
S74 | HKDGSsEKHKD | PhosphoSitePlus | |
Y444 | KDWQKyETARR | Topoisom_I | PhosphoSitePlus |
Y426 | QGSIKyIMLNP | Topoisom_I_N | PhosphoSitePlus |
S686 | KKVVEsKKKAV | Hanta_nucleocap | PhosphoSitePlus |
S506 | TVGCCsLRVEH | PhosphoSitePlus | |
S298 | IITNLsKCDFT | HPRD | |
S112 | ENGFSsPPQIK | PhosphoSitePlus; HPRD; phosphoELM | |
Y125 | PEDDGyFVPPK | PhosphoSitePlus; HPRD | |
T295 | EKNIItNLSKC | Topoisom_I_N | PhosphoSitePlus |
S10 | HLHNDsQIEAD | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
T649 | MMNLQtKIDAK | Topoisom_I; Hanta_nucleoc | PhosphoSitePlus |
Y426 | QGSIKyIMLNP | HPRD | |
S298 | IITNLsKCDFT | Topoisom_I_N | PhosphoSitePlus |
Dephosphorylation site |
TOP1_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000354522 | R449W | COSMIC | Ovarian Cancer | 20826764 |
ENSP00000354522 | A96S | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000354522 | P560L | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000354522 | D533G | HPI | Leukemia | 1849260 |
ENSP00000354522 | M319T | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000354522 | P560L | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000354522 | N623S | COSMIC | Breast Cancer | 20668451 |
ENSP00000354522 | K326R | HPI, COSMIC | Breast Cancer | 16959974 |
ENSP00000354522 | M370T | HPI | Leukemia | 7882333 |
ENSP00000354522 | T729A | HPI | Lung Cancer | 1332703 18772225 |
ENSP00000354522 | A96S | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000354522 | N722S | HPI | Leukemia | 7882333 18443285 11212241 9632354 8938793 7961822 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000354522 | Non-small cell lung carcinoma | Treatment (none vs CIGB-300 treatment) | cell line | Down | 0.5 | 20804217 |
Hyperphosphorylation site |
TOP1_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
ZAGL2_HUMAN | TOP1_HUMAN | kinase -> substrate | RegPhos |
ABL1_HUMAN | TOP1_HUMAN | kinase -> substrate | RegPhos |
CEBPB_HUMAN | TOP1_HUMAN | TF -> target gene | TRANSFAC |
Function Annotation |
KEGG Pathway |
TOP1_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0006338 | chromatin remodeling | IBA | biological_process |
GO:0005694 | chromosome | IEA | cellular_component |
GO:0040016 | embryonic cleavage | IEA | biological_process |
GO:0006265 | DNA topological change | IBA | biological_process |
GO:0042493 | response to drug | IEP | biological_process |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0016310 | phosphorylation | NAS | biological_process |
GO:0007059 | chromosome segregation | IBA | biological_process |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0006260 | DNA replication | IBA | biological_process |
GO:0005737 | cytoplasm | IEA | cellular_component |
GO:0012501 | programmed cell death | NAS | biological_process |
GO:0019048 | virus-host interaction | IEA | biological_process |
GO:0000932 | cytoplasmic mRNA processing body | IDA | cellular_component |
GO:0005654 | nucleoplasm | IDA | cellular_component |
GO:0031298 | replication fork protection complex | IBA | cellular_component |
GO:0006265 | DNA topological change | IEA | biological_process |
GO:0043204 | perikaryon | IEA | cellular_component |
GO:0003682 | chromatin binding | IDA | molecular_function |
GO:0006260 | DNA replication | IEA | biological_process |
GO:0005730 | nucleolus | IDA | cellular_component |
GO:0005634 | nucleus | IEA | cellular_component |
GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activi | IEA | molecular_function |
GO:0003917 | DNA topoisomerase type I activity | IDA | molecular_function |
GO:0003677 | DNA binding | IDA | molecular_function |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0000228 | nuclear chromosome | IDA | cellular_component |
GO:0003917 | DNA topoisomerase type I activity | IEA | molecular_function |